ALPS Advisors’s Ocular Therapeutix OCUL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-28,587
| Closed | -$177K | – | 870 |
|
|
2017
Q3 | $177K | Buy |
28,587
+2,386
| +9% | +$14.8K | ﹤0.01% | 760 |
|
|
2017
Q2 | $243K | Buy |
26,201
+1,462
| +6% | +$13.6K | ﹤0.01% | 736 |
|
|
2017
Q1 | $230K | Buy |
24,739
+830
| +3% | +$7.72K | ﹤0.01% | 706 |
|
|
2016
Q4 | $200K | Sell |
23,909
-7,734
| -24% | -$64.7K | ﹤0.01% | 697 |
|
|
2016
Q3 | $217K | Sell |
31,643
-3,149
| -9% | -$21.6K | ﹤0.01% | 655 |
|
|
2016
Q2 | $172K | Buy |
34,792
+6,976
| +25% | +$34.5K | ﹤0.01% | 601 |
|
|
2016
Q1 | $269K | Sell |
27,816
-4,767
| -15% | -$46.1K | ﹤0.01% | 584 |
|
|
2015
Q4 | $305K | Sell |
32,583
-6,082
| -16% | -$56.9K | ﹤0.01% | 649 |
|
|
2015
Q3 | $5.44K | Buy |
38,665
+14,182
| +58% | +$1.99K | 0.01% | 271 |
|
|
2015
Q2 | $515K | Buy |
+24,483
| New | +$515K | ﹤0.01% | 472 |
|